Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 7 of 35

ACTIVE NOT RECRUITING NA

Effect of Preoperative Diet on Perioperative Gut Microbiome

NCT05027763

ACTIVE NOT RECRUITING Phase 2

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

NCT05119296

ACTIVE NOT RECRUITING Phase 2

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

NCT04925544

ACTIVE NOT RECRUITING NA

Maternal & Offspring Microbiome Study

NCT05123612

ACTIVE NOT RECRUITING

AN/BN Risk Factors Study

NCT05133037

ACTIVE NOT RECRUITING

Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure

NCT04313712

ACTIVE NOT RECRUITING NA

Neonatal Brain Oxygenation Study

NCT04439968

ACTIVE NOT RECRUITING NA

Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS

NCT04870255

ACTIVE NOT RECRUITING NA

Rapid Acting Transcranial Magnetic Stimulation

NCT04739969

ACTIVE NOT RECRUITING NA

Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation

NCT04243798

ACTIVE NOT RECRUITING NA

Transcranial Direct Current to Treat Epilepsy at Home

NCT04309812

ACTIVE NOT RECRUITING Phase 2

Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

NCT04577300

ACTIVE NOT RECRUITING NA

Integrating Support Persons Into Recovery

NCT04239235

ACTIVE NOT RECRUITING Phase 2

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

NCT04727242

ACTIVE NOT RECRUITING

Neural Circuit Biomarkers of Transcranial Magnetic Stimulation Study

NCT04663841

ACTIVE NOT RECRUITING

SPRINT: Signature for Pain Recovery IN Teens

NCT04285112

ACTIVE NOT RECRUITING NA

Perioperative Optimization With Enhanced Recovery

NCT04504266

ACTIVE NOT RECRUITING Phase 3

Opiate Suicide Study in Patients With Major Depression

NCT04116528

ACTIVE NOT RECRUITING NA

Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test

NCT03893500

ACTIVE NOT RECRUITING NA

Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation

NCT03925597

ACTIVE NOT RECRUITING Phase 1

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

NCT04088864

ACTIVE NOT RECRUITING NA

Supportive Care for Cognitively Impaired Patients and Families

NCT03881579

ACTIVE NOT RECRUITING NA

Listening to Mom 2: Neural, Clinical and Language Outcomes

NCT04193579

ACTIVE NOT RECRUITING

Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG)

NCT03629743

ACTIVE NOT RECRUITING NA

Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation

NCT03681262

ACTIVE NOT RECRUITING

AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study

NCT03991156

ACTIVE NOT RECRUITING NA

A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism

NCT03778827

ACTIVE NOT RECRUITING NA

Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)

NCT03968055

ACTIVE NOT RECRUITING

Neural Mechanisms of Decision Making in Hoarding Disorder

NCT03487224

ACTIVE NOT RECRUITING NA

Precision Diets for Diabetes Prevention

NCT03919877

ACTIVE NOT RECRUITING NA

Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)

NCT03834844

ACTIVE NOT RECRUITING NA

Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer

NCT05112198

ACTIVE NOT RECRUITING Phase 1

Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies

NCT03241940

ACTIVE NOT RECRUITING Phase 1

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

NCT03233854

ACTIVE NOT RECRUITING NA

Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

NCT03511534

ACTIVE NOT RECRUITING Phase 2

Understanding How Ketamine Brings About Rapid Improvement in OCD

NCT02624596

ACTIVE NOT RECRUITING Phase 2

Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration

NCT02862938

ACTIVE NOT RECRUITING Phase 2

Pilot Trial of Pregnenolone in Autism

NCT02627508

ACTIVE NOT RECRUITING NA

Stanford Center for Back Pain

NCT02503475

ACTIVE NOT RECRUITING NA

MyHeart Counts Cardiovascular Health Study

NCT03090321

ACTIVE NOT RECRUITING NA

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

NCT02346253

ACTIVE NOT RECRUITING NA

Feasibility Neurocognitive Outcome After Transplant

NCT02300961

ACTIVE NOT RECRUITING Phase 1

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

NCT00319657

ACTIVE NOT RECRUITING NA

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

NCT00185744

NOT YET RECRUITING NA

Acoustic Resonance Therapy for Treating Empty Nose Syndrome

NCT07215013

NOT YET RECRUITING Early Phase 1

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

NCT07577999

NOT YET RECRUITING NA

Simplifying Diet Tracking in a Digital Weight Loss Intervention

NCT07601061

NOT YET RECRUITING NA

Vagus Nerve Stimulation to Enhance Memory in Aging

NCT07214194

NOT YET RECRUITING Phase 2

Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism

NCT07635862

NOT YET RECRUITING NA

Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

NCT07522190

← Previous Page 7 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.